Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. (SHE:300937)
China · Delayed Price · Currency is CNY 24.58
-0.78 (-3.08%)
At close: Jul 16, 2026
SHE:300937 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | -19.76 | -12.85 | 13.2 | 59.53 | 42.02 | 6.4 |
Depreciation & Amortization | 26.86 | 26.86 | 31.51 | 24.37 | 23.85 | 16.57 |
Other Amortization | 10.26 | 10.26 | 8.59 | 6.12 | 3.06 | 1.92 |
Loss (Gain) From Sale of Assets | 0.01 | 0.01 | 0.61 | 0.05 | 0.08 | 0.11 |
Asset Writedown & Restructuring Costs | 5.89 | 5.89 | -0.53 | 0.01 | 20.14 | 6.46 |
Loss (Gain) From Sale of Investments | 0.36 | 0.36 | 1.84 | -1.54 | 4.29 | -7.52 |
Provision & Write-off of Bad Debts | 10.19 | 10.19 | 6.17 | 9.89 | - | - |
Other Operating Activities | 62.93 | 15.25 | 19.52 | 19.46 | 0.48 | 2.15 |
Change in Accounts Receivable | -5.88 | -5.88 | -2.48 | -30.26 | -18.43 | -73.83 |
Change in Inventory | -54.41 | -54.41 | 33.64 | -117.3 | 18.95 | -133.44 |
Change in Accounts Payable | 2.85 | 2.85 | 23.45 | -79.43 | 62.6 | 28.88 |
Operating Cash Flow | 27.55 | -13.23 | 124.43 | -115.47 | 152.67 | -154.38 |
Operating Cash Flow Growth | -87.87% | - | - | - | - | - |
Capital Expenditures | -8.35 | -7.57 | -32.41 | -35.33 | -18.32 | -31.43 |
Sale of Property, Plant & Equipment | 7.9 | 7.89 | 0.74 | 0.54 | 0.08 | 0.01 |
Cash Acquisitions | - | - | 0 | 0.07 | 20.89 | - |
Divestitures | - | - | 1.01 | 3.03 | 0.33 | -0.09 |
Investment in Securities | -160.6 | -23.39 | -19.73 | -7.72 | -13.68 | -100.62 |
Other Investing Activities | 44.01 | 44.01 | 0.65 | -95.64 | 0.32 | 0.19 |
Investing Cash Flow | -117.04 | 20.94 | -49.74 | -135.04 | -10.39 | -131.93 |
Short-Term Debt Issued | - | 390.32 | 457.5 | 330.5 | 185.42 | 130.2 |
Total Debt Issued | 430.31 | 390.32 | 457.5 | 330.5 | 185.42 | 130.2 |
Short-Term Debt Repaid | - | -434.11 | -454 | -195.42 | -119.2 | -51 |
Long-Term Debt Repaid | - | -6.51 | -8.42 | -6.26 | -5.88 | -3.79 |
Total Debt Repaid | -370.61 | -440.61 | -462.42 | -201.68 | -125.08 | -54.79 |
Net Debt Issued (Repaid) | 59.7 | -50.3 | -4.92 | 128.82 | 60.34 | 75.41 |
Issuance of Common Stock | 0.92 | 0.74 | 0.3 | - | - | - |
Common Dividends Paid | -17.12 | -17.76 | -30.25 | -24.12 | -5.31 | -20.67 |
Other Financing Activities | -0.18 | -12.95 | - | 2.71 | 2.16 | 272.06 |
Financing Cash Flow | 43.31 | -80.26 | -34.88 | 107.42 | 57.18 | 326.8 |
Foreign Exchange Rate Adjustments | -0.01 | -0 | 0 | -0 | -0 | - |
Net Cash Flow | -46.19 | -72.55 | 39.82 | -143.1 | 199.47 | 40.49 |
Free Cash Flow | 19.2 | -20.8 | 92.02 | -150.8 | 134.35 | -185.81 |
Free Cash Flow Growth | -90.22% | - | - | - | - | - |
Free Cash Flow Margin | 0.43% | -0.47% | 2.09% | -3.40% | 3.38% | -5.46% |
Free Cash Flow Per Share | 0.21 | -0.22 | 1.19 | -1.57 | 1.41 | -2.03 |
Cash Income Tax Paid | 86.92 | 83.72 | 59.02 | 65.36 | 44.38 | 30.78 |
Levered Free Cash Flow | 176.01 | 150.7 | 18.19 | -195.93 | 177.55 | -201.21 |
Unlevered Free Cash Flow | 181.32 | 156.38 | 24.26 | -191.82 | 181.57 | -200.07 |
Change in Working Capital | -69.2 | -69.2 | 43.52 | -233.37 | 58.74 | -180.48 |